47 related articles for article (PubMed ID: 19698761)
1. High content imaging-based assay to classify estrogen receptor-α ligands based on defined mechanistic outcomes.
Ashcroft FJ; Newberg JY; Jones ED; Mikic I; Mancini MA
Gene; 2011 May; 477(1-2):42-52. PubMed ID: 21256200
[TBL] [Abstract][Full Text] [Related]
2. AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.
Kiliti AJ; Sharif GM; Martin MB; Wellstein A; Riegel AT
Front Endocrinol (Lausanne); 2023; 14():1250218. PubMed ID: 37711895
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer.
Zheng J; Huang J; Xia J; Zhou W; Dai L; Lin S; Gao L; Zou C
Front Oncol; 2023; 13():1038787. PubMed ID: 36814821
[TBL] [Abstract][Full Text] [Related]
4. Targeting transcription factors in cancer - from undruggable to reality.
Bushweller JH
Nat Rev Cancer; 2019 Nov; 19(11):611-624. PubMed ID: 31511663
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Tamoxifen and N-Desmethyl Tamoxifen Protein Targets in MCF-7 Cells Using Large-Scale Protein Folding and Stability Measurements.
Ogburn RN; Jin L; Meng H; Fitzgerald MC
J Proteome Res; 2017 Nov; 16(11):4073-4085. PubMed ID: 28927269
[TBL] [Abstract][Full Text] [Related]
6. The complex nature of oestrogen signalling in breast cancer: enemy or ally?
Lipovka Y; Konhilas JP
Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27160081
[TBL] [Abstract][Full Text] [Related]
7. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.
Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T
Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549
[TBL] [Abstract][Full Text] [Related]
8. Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients.
Jóri B; Kamps R; Xanthoulea S; Delvoux B; Blok MJ; Van de Vijver KK; de Koning B; Oei FT; Tops CM; Speel EJ; Kruitwagen RF; Gomez-Garcia EB; Romano A
Oncotarget; 2015 Dec; 6(38):41108-22. PubMed ID: 26517685
[TBL] [Abstract][Full Text] [Related]
9. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.
Chakravarty D; Sboner A; Nair SS; Giannopoulou E; Li R; Hennig S; Mosquera JM; Pauwels J; Park K; Kossai M; MacDonald TY; Fontugne J; Erho N; Vergara IA; Ghadessi M; Davicioni E; Jenkins RB; Palanisamy N; Chen Z; Nakagawa S; Hirose T; Bander NH; Beltran H; Fox AH; Elemento O; Rubin MA
Nat Commun; 2014 Nov; 5():5383. PubMed ID: 25415230
[TBL] [Abstract][Full Text] [Related]
10. Nuclear receptor modulation--role of coregulators in selective estrogen receptor modulator (SERM) actions.
Feng Q; O'Malley BW
Steroids; 2014 Nov; 90():39-43. PubMed ID: 24945111
[TBL] [Abstract][Full Text] [Related]
11. A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen.
Lebedeva G; Yamaguchi A; Langdon SP; Macleod K; Harrison DJ
BMC Syst Biol; 2012 Nov; 6():138. PubMed ID: 23134774
[TBL] [Abstract][Full Text] [Related]
12. Mapping of lamin A- and progerin-interacting genome regions.
Kubben N; Adriaens M; Meuleman W; Voncken JW; van Steensel B; Misteli T
Chromosoma; 2012 Oct; 121(5):447-64. PubMed ID: 22610065
[TBL] [Abstract][Full Text] [Related]
13. The function of steroid receptor coactivator-1 in normal tissues and cancer.
Walsh CA; Qin L; Tien JC; Young LS; Xu J
Int J Biol Sci; 2012; 8(4):470-85. PubMed ID: 22419892
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of two-channel ChIP-on-chip and DNA methylation microarray normalization strategies.
Adriaens ME; Jaillard M; Eijssen LM; Mayer CD; Evelo CT
BMC Genomics; 2012 Jan; 13():42. PubMed ID: 22276688
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1.
Liu Y; Mayo MW; Nagji AS; Smith PW; Ramsey CS; Li D; Jones DR
Oncogene; 2012 Mar; 31(9):1143-54. PubMed ID: 21765477
[TBL] [Abstract][Full Text] [Related]
16. Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy.
Johnson AB; O'Malley BW
Mol Cell Endocrinol; 2012 Jan; 348(2):430-9. PubMed ID: 21664237
[TBL] [Abstract][Full Text] [Related]
17. ERasing breast cancer resistance through the kinome.
Johnson AB; O'Malley BW
Nat Med; 2011 Jun; 17(6):660-1. PubMed ID: 21647142
[No Abstract] [Full Text] [Related]
18. Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling.
Dassen H; Punyadeera C; Delvoux B; Schulkens I; Marchetti C; Kamps R; Klomp J; Dijcks F; de Goeij A; D'Hooghe T; Kyama C; Ederveen A; Dunselman G; Groothuis P; Romano A
Am J Pathol; 2010 Nov; 177(5):2495-508. PubMed ID: 21048224
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel ER-alpha target genes in breast cancer cells: gene- and cell-selective co-regulator recruitment at target promoters determines the response to 17beta-estradiol and tamoxifen.
Romano A; Adriaens M; Kuenen S; Delvoux B; Dunselman G; Evelo C; Groothuis P
Mol Cell Endocrinol; 2010 Jan; 314(1):90-100. PubMed ID: 19698761
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
